No recent ownership filings for this insider.
| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | Aug 29, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 16.3 | -225,000 | -12.03% | ✗ | $6.4M |
| Jul 17, 2025 | Jul 18, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 42.5 | -19,725 | -1.04% | ✓ | $398.7K |
| Jul 14, 2025 | Jul 16, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 27.5 | -139,365 | -5.89% | ✓ | $2.8M |
| Jan 29, 2025 | Jan 30, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,824 | -0.14% | ✗ | $83.4K |
| Jan 22, 2025 | Jan 23, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 42.5 | -13,551 | -0.69% | ✗ | $412.3K |
| Jan 17, 2025 | Jan 21, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 90.0 | +124,655 | 6.75% | ✗ | $180K |
| Jan 13, 2025 | Jan 14, 2025 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -6,247 | -0.34% | ✗ | $179.3K |
| Mar 1, 2024 | Mar 5, 2024 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 17.5 | -250,000 | -10.94% | ✓ | $16M |
| Feb 12, 2024 | Feb 13, 2024 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 45.0 | -3,962 | -0.19% | ✗ | $268.5K |
| Jan 29, 2024 | Jan 31, 2024 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,843 | -0.14% | ✗ | $182.3K |
| Jan 22, 2024 | Jan 23, 2024 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 42.5 | -13,431 | -0.65% | ✗ | $873K |
| Jan 16, 2024 | Jan 17, 2024 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 90.0 | +64,243 | 3.23% | ✗ | $524.5K |
| Nov 21, 2023 | Nov 21, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -5,000 | -0.25% | ✗ | $244K |
| Sep 1, 2023 | Sep 1, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 16.3 | -150,000 | -6.99% | ✗ | $6.3M |
| May 16, 2023 | May 18, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -30,000 | -1.62% | ✓ | $2.6M |
| Apr 18, 2023 | Apr 20, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -30,000 | -1.63% | ✓ | $2.5M |
| Mar 21, 2023 | Mar 23, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -30,000 | -1.76% | ✓ | $1.9M |
| Feb 21, 2023 | Feb 22, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 72.5 | +12,306 | 0.79% | ✗ | $93.7K |
| Feb 10, 2023 | Feb 14, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -3,958 | -0.25% | ✗ | $202.7K |
| Jan 27, 2023 | Jan 30, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,879 | -0.18% | ✗ | $151.9K |
| Jan 20, 2023 | Jan 24, 2023 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 30.0 | -9,453 | -0.60% | ✗ | $492K |
| Apr 25, 2022 | Dec 21, 2022 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 40.0 | -40,700 | -1.17% | ✓ | $1.5M |
| Feb 10, 2022 | Feb 14, 2022 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,523 | -0.17% | ✗ | $118.9K |
| Jan 28, 2022 | Feb 1, 2022 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,024 | -0.13% | ✗ | $78.1K |
| Feb 10, 2021 | Feb 11, 2021 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 47.5 | -2,523 | -0.17% | ✗ | $120.4K |
| Dec 15, 2020 | Dec 16, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 46.3 | -5,000 | -0.37% | ✓ | $260.8K |
| Nov 16, 2020 | Nov 17, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.38% | ✓ | $196.9K |
| Oct 15, 2020 | Oct 16, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.38% | ✓ | $172.3K |
| Sep 15, 2020 | Sep 16, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.38% | ✓ | $154.8K |
| Aug 20, 2020 | Aug 21, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -3,457 | -0.26% | ✓ | $103.7K |
| Aug 18, 2020 | Aug 20, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 53.8 | -1,543 | -0.12% | ✓ | $46.3K |
| Jul 15, 2020 | Jul 16, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.37% | ✓ | $160.6K |
| Jun 15, 2020 | Jun 16, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.37% | ✓ | $151.1K |
| May 15, 2020 | May 19, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.37% | ✓ | $149.6K |
| Apr 15, 2020 | Apr 17, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.37% | ✓ | $148.9K |
| Mar 16, 2020 | Mar 18, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 38.8 | -35,637 | -2.69% | ✓ | $759.9K |
| Feb 18, 2020 | Feb 20, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 36.3 | -35,637 | -2.75% | ✓ | $1.4M |
| Jan 15, 2020 | Jan 17, 2020 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 36.3 | -35,638 | -2.80% | ✓ | $1.5M |
| Dec 16, 2019 | Dec 17, 2019 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.40% | ✓ | $139.8K |
| Nov 15, 2019 | Nov 18, 2019 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.40% | ✓ | $136.4K |
| Oct 15, 2019 | Oct 16, 2019 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.40% | ✓ | $131.6K |
| Sep 16, 2019 | Sep 17, 2019 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 48.8 | -5,000 | -0.40% | ✓ | $132.9K |
| Aug 15, 2019 | Aug 16, 2019 | Apellis Pharmaceuticals, Inc. | CEO | Sell | 45.0 | -10,000 | -0.81% | ✓ | $268K |